A Phase 4 interventional study of Pregabalin and Ibuprofen (400 mg) in Post Operative Pain, Spine Surgery and Preemptive Analgesia, sponsored by Universitas Indonesia. Completed at 1 site in Indonesia. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Universitas Indonesia · Phase 4, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 66 studies testing pregabalin in Pain, Postoperative — 7 open to participants now, 7 under way, 1 of them phase 3. Pregabalin · Pain, Postoperative.
Among the 66 studies testing pregabalin in Pain, Postoperative, this one is the 48th largest by enrollment, is one of 3 that started in 2026, is one of 22 in phase 4, and was the 66th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,240 are open to participants now.
Browse Pain, Postoperative studies →7 of the 66 studies testing pregabalin in Pain, Postoperative are open now, in 5 countries. Recruiting first, the newest first:
Moumtzidou Maria Aikaterini · Sites in Greece
Ages 18+ · Women only
Tanta University · Sites in Egypt
Ages 21–60
Bahrain Defence Force Hospital · Sites in Bahrain
Ages 18–85
Medical University of Warsaw · Sites in Poland
Ages 18+
Ain Shams University · Sites in Egypt
Ages 21–45 · Women only · Healthy volunteers
By country, each count listing its studies:
Pregabalin: first FDA approval 2004 (LYRICA), first EMA approval 2004. What it is approved for, and how studies give it, is on its page →
Of the 675 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 328 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
66 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 10 · Phase 3 20 · Phase 4 22
First in 2005; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 65 is below the median of 75 across 4,854 interventional studies indexed under Pain, Postoperative.
Median enrollment 90 across the 66 interventional studies. Of the 47 that completed or were terminated, 17 (36%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 66 have an industry lead sponsor. The 10 most frequent:
Universitas Indonesia is the lead sponsor of 39 studies on the registry; 13 are open to participants now.
Universitas Indonesia has 4 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
3 of the studies testing pregabalin in Pain, Postoperative that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05150795Ain Shams UniversityEffect of Preoperative Oral Pregabalin Versus Intraoperative Fentanyl on Postoperative Analgesia | 2026-12 |
| NCT07344467Tanta UniversityOral Melatonin Versus Oral Pregabalin on Postoperative Pain and Anxiety Following Spine Surgery | 2027-06-01 |
| NCT07880223Moumtzidou Maria AikateriniComparison of Two Postoperative Care Strategies After Breast Surgery | 2027-08 |
Add all 3 to your calendar (.ics) → With an account.
Among the 66 studies testing pregabalin in Pain, Postoperative, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn if combining pregabalin and ibuprofen, given before surgery (preemptive analgesia), works to reduce pain after spine surgery in adults aged 18-60 years. The main questions it aims to answer are:
Does the combination of pregabalin and ibuprofen lower postoperative pain scores (VAS) over the first 24 hours after surgery? Does it lengthen the time until a patient first needs additional pain relief (morphine through a patient-controlled analgesia, or PCA, device)? Does it reduce the total amount of additional morphine needed in 24 hours? Does it shorten the length of hospital stay?
Researchers will compare the combination of pregabalin and ibuprofen to a control (a sugar capsule and 0.9% saline, which contain no active drug) to see if the combination works to treat pain after spine surgery. All participants will also receive the standard pain medicines paracetamol and ketorolac.
Participants will:
Take pregabalin 150 mg by mouth 2 hours before surgery and receive ibuprofen 400 mg by vein 30 minutes before anesthesia induction, or take a sugar capsule and receive 0.9% saline at the same times Undergo elective spine surgery under general anesthesia Use a PCA morphine device after waking from anesthesia whenever they feel pain (VAS above 4) Rate their pain on a visual analogue scale (VAS) at hours 0, 1, 2, 4, 8, 12, and 24 after surgery Be followed until hospital discharge
Background and Rationale
Spine surgery is associated with substantial postoperative pain. Reports describe chronic pain in about 40% of patients after spinal fusion, and a systematic review found that nearly 80% of patients experience postoperative pain after spine surgery, with 86% of them reporting moderate to severe pain. Uncontrolled pain can delay mobilization and prolong hospital stay. At Cipto Mangunkusumo National General Hospital (RSCM), there is no clinical practice guideline for postoperative pain management after spine surgery. Patients routinely receive the same regimen of paracetamol and ketorolac, yet pain scores peak around 3 to 4 hours after surgery at VAS 4 to 5.
Preemptive analgesia aims to reduce postoperative pain by giving analgesics before the surgical stimulus, limiting peripheral and central sensitization. Pregabalin acts centrally by binding the alpha-2-delta subunit of voltage-gated calcium channels, reducing release of excitatory neurotransmitters. Ibuprofen acts peripherally by inhibiting cyclooxygenase and reducing prostaglandin synthesis. Because the two drugs act through different pathways, their combination is expected to provide multimodal analgesia that is better than either drug alone. Evidence for this specific combination in spine surgery is limited, and it has not been evaluated at RSCM.
Hypothesis
Preemptive pregabalin plus ibuprofen is better than control in lowering postoperative pain scores, lengthening the time to the first additional analgesic, reducing the total additional analgesic requirement, and shortening hospital stay after spine surgery.
Study Design
This is a single-blind (participant-masked), randomized controlled trial conducted at RSCM, Jakarta, Indonesia. Participants are recruited by consecutive sampling and allocated by simple randomization. The random sequence is generated by an assistant who is not involved in the study, and allocations are kept in sealed, opaque envelopes opened by the anesthesia resident one hour before surgery. The sample size was calculated at 28 participants per group, and with an additional 20% for dropouts, 34 per group (68 in total) were planned.
All participants receive standardized general anesthesia and the same routine postoperative analgesia (paracetamol and ketorolac). After extubation, each participant is given a patient-controlled analgesia (PCA) device containing morphine 0.5 mg/mL, with a 15-minute lock-out interval, to be used when pain exceeds VAS 4. Antiemetic and antihistamine drugs and resuscitation equipment are available to manage morphine-related adverse effects. Pain is assessed with a visual analogue scale (VAS), supported by a pain-scale card to help participants. The time to first additional analgesia is measured from extubation to the first PCA press, and the total additional analgesia is the cumulative morphine dose delivered by the PCA over 24 hours. Length of stay is measured from the end of surgery to discharge.
Statistical Analysis
Data are analyzed with SPSS. Normality is tested with the Shapiro-Wilk test. Normally distributed data are presented as mean ± standard deviation and compared with the unpaired t-test; non-normally distributed data are presented as median (minimum-maximum) and compared with the Mann-Whitney test. Categorical data are compared with the chi-square test, or Fisher's exact test when expected counts are below 5. A p-value below 0.05 is considered statistically significant.
Ethics
The study was approved by the Health Research Ethics Committee of the Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital. Written informed consent is obtained from all participants after explanation of the study's aims, procedures, benefits, and risks.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Pregabalin 150 mg orally 2 hours before surgery and ibuprofen 400 mg intravenously 30 minutes before anesthesia induction. All participants also receive standard paracetamol and ketorolac, and a morphine PCA after extubation.
Drug: Pregabalin · Drug: Ibuprofen (400 mg)
Sugar capsule orally 2 hours before surgery and 0.9% sodium chloride intravenously 30 minutes before anesthesia induction. All participants also receive standard paracetamol and ketorolac, and a morphine PCA after extubation.
Other: Placebo
150 mg orally, single dose, 2 hours before surgery.
400 mg intravenously, single dose, 30 minutes before anesthesia induction.
Sugar capsule orally 2 hours before surgery and 0.9% sodium chloride intravenously 30 minutes before anesthesia induction.
Postoperative pain score (Visual Analogue Scale)
Pain intensity measured with the Visual Analogue Scale (VAS), 0 to 10, where 0 is no pain and 10 is the worst pain imaginable. Higher scores mean worse pain. Assessed at hour 0 (after extubation), 1, 2, 4, 8, 12, and 24 after the end of surgery, and compared between the pregabalin + ibuprofen group and the control group
Time frame: 0, 1, 2, 4, 8, 12, and 24 hours after the end of surgery
Time to first additional analgesia (minutes from extubation to first PCA morphine press)
Time from extubation to the first press of the patient-controlled analgesia (PCA) device containing morphine 0.5 mg/mL, used as additional analgesia when the patient reports pain (VAS above 4). The PCA has a 15-minute lock-out interval. Compared between the pregabalin + ibuprofen group and the control group
Time frame: Up to 24 hours after extubation
Total additional analgesia (cumulative PCA morphine dose, mg)
Total dose of morphine (mg) delivered by the patient-controlled analgesia (PCA) device (0.5 mg/mL, 15-minute lock-out) from extubation until 24 hours afterward, used as additional analgesia when pain exceeds VAS 4. Compared between the pregabalin + ibuprofen group and the control group.
Time frame: 24 hours after extubation
Length of hospital stay (days from end of surgery to discharge)
Number of days from the end of surgery until the patient is allowed to go home by the surgeon. Compared between the pregabalin + ibuprofen group and the control group.
Time frame: From end of surgery until hospital discharge, assessed up to 30 days
Incidence of significant pain (VAS > 3 at any time point)
Proportion of participants with significant pain, defined as a VAS score above 3 at one or more of the seven measurement points (hours 0, 1, 2, 4, 8, 12, and 24 after the end of surgery). Compared between the pregabalin + ibuprofen group and the control group.
Time frame: 0 to 24 hours after surgery
Ran from Jun 2026 to primary completion in Oct 2026, 4 months.
Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's 4 months is below that.
Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Pregabalin · Ibuprofen
Universitas Indonesia